Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Rimoldi

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|November 3, 1995
Expression of MAGE genes in primary and metastatic cutaneous melanomaF Brasseur, D Rimoldi, D Liénard, et al.
Melanoma Research|July 26, 2002
Frequent downregulation of Fas (CD95) expression and function in melanomaR R Bullani, P Wehrli, I Viard-Leveugle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
CD8+ T-cell response to NY-ESO-1: relative antigenicity and in vitro immunogenicity of natural and analogue sequencesP Romero, V Dutoit, V Rubio-Godoy, et al.
Cancer Research|August 27, 1999
Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376D Valmori, M J Pittet, C Vonarbourg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogueD Valmori, F Lévy, I Miconnet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2000
Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patientsD Valmori, V Dutoit, D Liénard, et al.
European Journal of Immunology|June 26, 1999
CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patientsD E Speiser, D Valmori, D Rimoldi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 1998
Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptideD Valmori, N Gervois, D Rimoldi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2001
Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-lifeV Rubio-Godoy, V Dutoit, D Rimoldi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptideM J Pittet, D E Speiser, D Liénard, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|November 3, 1995
Expression of MAGE genes in primary and metastatic cutaneous melanomaF Brasseur, D Rimoldi, D Liénard, et al.
Melanoma Research|July 26, 2002
Frequent downregulation of Fas (CD95) expression and function in melanomaR R Bullani, P Wehrli, I Viard-Leveugle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
CD8+ T-cell response to NY-ESO-1: relative antigenicity and in vitro immunogenicity of natural and analogue sequencesP Romero, V Dutoit, V Rubio-Godoy, et al.
Cancer Research|August 27, 1999
Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376D Valmori, M J Pittet, C Vonarbourg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogueD Valmori, F Lévy, I Miconnet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2000
Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patientsD Valmori, V Dutoit, D Liénard, et al.
European Journal of Immunology|June 26, 1999
CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patientsD E Speiser, D Valmori, D Rimoldi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 1998
Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptideD Valmori, N Gervois, D Rimoldi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2001
Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-lifeV Rubio-Godoy, V Dutoit, D Rimoldi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptideM J Pittet, D E Speiser, D Liénard, et al.
Pageof 7